Macromoltek

Y Combinator LogoW18ActiveTherapeuticsDeep LearningAI-powered Drug Discovery

Computational antibody design

Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

Jobs at Macromoltek

Macromoltek
Founded:2010
Team Size:14
Location:Austin, TX

Active Founders

Monica Berrondo, CEO

Monica Berrondo, Ph.D., is an entrepreneur, scientist, and software engineer. Her expertise lies in antibody structure-prediction and analysis, protein functional analysis, protein mutational analysis, and computational approaches to complex scientific problems.

Monica Berrondo
Monica Berrondo
Macromoltek

Susana Kaufmann, CTO

Susana Kaufmann
Susana Kaufmann
Macromoltek